DrugPatentWatch Database Preview

Cipla Company Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CIPLA, and when can generic versions of CIPLA drugs launch?

CIPLA has eighty-seven approved drugs.

There are four US patents protecting CIPLA drugs. There are thirty-one tentative approvals on CIPLA drugs.

There are twenty-three patent family members on CIPLA drugs in twenty-one countries and three hundred and ten supplementary protection certificates in sixteen countries.

Summary for Cipla

International Patents:	23
US Patents:	4
Tradenames:	77
Ingredients:	77
NDAs:	87
Patent Litigation for Cipla:	See patent lawsuits for Cipla
PTAB Cases with Cipla as petitioner:	See PTAB cases with Cipla as petitioner

Drugs and US Patents for Cipla

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cipla Ltd	STAVUDINE	stavudine	FOR SOLUTION;ORAL	078030-001	Mar 20, 2009		DISCN	No	No
Cipla Usa	ZEMDRI	plazomicin sulfate	SOLUTION;INTRAVENOUS	210303-001	Jun 25, 2018		RX	Yes	Yes	9,266,919
Cipla	CINACALCET HYDROCHLORIDE	cinacalcet hydrochloride	TABLET;ORAL	208915-003	Mar 8, 2018	AB	RX	No	No
Cipla Ltd	ZALEPLON	zaleplon	CAPSULE;ORAL	077505-001	Jun 20, 2008	AB	RX	No	No
Cipla Ltd	GRANISETRON HYDROCHLORIDE	granisetron hydrochloride	INJECTABLE;INJECTION	078262-001	Dec 31, 2007	AP	RX	No	No
Cipla	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077137-001	Jul 2, 2007	AB	RX	No	No

International Patents for Cipla Drugs

Country	Patent Number	Estimated Expiration
Taiwan	I425947
Mexico	2010005632
China	101868472
Japan	2011504508
Canada	2706369
Slovenia	2217610

Supplementary Protection Certificates for Cipla Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0273277	SPC/GB96/049	United Kingdom		PRODUCT NAME: STAVUDINE; REGISTERED: UK EU/1/96/009/001 19960508; UK EU/1/96/009/002 19960508; UK EU/1/96/009/003 19960508; UK EU/1/96/009/004 19960508; UK EU/1/96/009/005 19960508; UK EU/1/96/009/006 19960508; UK EU/1/96/009/007 19960508; UK EU/1/96/009/008 19960508; UK EU/1/96/009/009 19960508
1301519	1690012-8	Sweden		PRODUCT NAME: TENOFOVIR ALAFENAMIDE OR A SALT OR SOLVATE THEREOF, IN PARTICULAR TENOFOVIR ALAFENAMIDE FUMARATE; REG. NO/DATE: EU/1/15/1061/001-002 20151123
0265685	C980030	Netherlands		PRODUCT NAME: FELODIPINE, DESGEWENST IN DE VORM VAN FYSIOLOGISCH AANVAARDBAAR ZOUT, EN (2S, 3AS, 6AS)-1-[(S)-N-[(S)-1-CARBOXY-3-FENYLPROPYL]A LANYL]OCTAHYDROCYCLOPENTA[B]-PYRROOL-2-CARBONZUUR (RAMIPRILAAT) , DESGEWENST IN DE VORM VAN EEN .....ZIE VERDER IN HET DOSSIER; NAT. REGISTRATION NO/ DATE: RVG 22449, RVG 22450 19980618; FIRST REGISTRATION: SE 13596, 13597 19970919
1301519	CA 2016 00012	Denmark		PRODUCT NAME: TENOFOVIRALAFENAMID ELLER ET SALT ELLER SOLVAT DERAF, I SAERDELESHED TENOFOVIRALAFENAMIDFUMARAT; REG. NO/DATE: EU/1/15/1061/001-002 20151123
2822954	18C1035	France		PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625
0253738	C960002	Netherlands		PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Cipla
• Cipla Ltd
• Cipla Usa